142 related articles for article (PubMed ID: 17308917)
1. Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations.
Rabenau HF; Marianov B; Wicker S; Allwinn R
Med Microbiol Immunol; 2007 Sep; 196(3):151-5. PubMed ID: 17308917
[TBL] [Abstract][Full Text] [Related]
2. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.
Cohen BJ; Parry RP; Doblas D; Samuel D; Warrener L; Andrews N; Brown D
J Virol Methods; 2006 Feb; 131(2):209-12. PubMed ID: 16188328
[TBL] [Abstract][Full Text] [Related]
3. Neutralization enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.
Nates SV; Rey GY; Giordano MO; Depetris AR; Boshell J
Viral Immunol; 1995; 8(1):47-52. PubMed ID: 8546804
[TBL] [Abstract][Full Text] [Related]
4. Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.
Bouche F; Ammerlaan W; Berthet F; Houard S; Schneider F; Muller CP
J Clin Microbiol; 1998 Mar; 36(3):721-6. PubMed ID: 9508302
[TBL] [Abstract][Full Text] [Related]
5. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
Cohen BJ; Doblas D; Andrews N
Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
[TBL] [Abstract][Full Text] [Related]
6. Determination of immunity to measles virus in young adults: comparative evaluation of a commercial enzyme immunoassay and the hemagglutination inhibition techniques.
Duvdevani P; Varsano N; Slepon R; Lerman Y; Shohat T; Mendelson E
Clin Diagn Virol; 1996 Oct; 7(1):1-6. PubMed ID: 9077425
[TBL] [Abstract][Full Text] [Related]
7. Protective titres of measles neutralising antibody.
Lee MS; Nokes DJ; Hsu HM; Lu CF
J Med Virol; 2000 Dec; 62(4):511-7. PubMed ID: 11074481
[TBL] [Abstract][Full Text] [Related]
8. Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay.
van den Hof S; van Gageldonk-Lafeber AB; van Binnendijk RS; van Gageldonk PG; Berbers GA
Vaccine; 2003 Oct; 21(27-30):4210-4. PubMed ID: 14505900
[TBL] [Abstract][Full Text] [Related]
9. A simplified immunoassay based on measles virus recombinant hemagglutinin protein for testing the immune status of vaccinees.
Bouche F; Ammerlaan W; Fournier P; Schneider F; Muller CP
J Virol Methods; 1998 Sep; 74(1):77-87. PubMed ID: 9763131
[TBL] [Abstract][Full Text] [Related]
10. An enzyme immunoassay based micro-neutralization test for titration of antibodies to human cytomegalovirus (CMV) and its correlation with direct ELISA measuring CMV IgG antibodies.
Gupta CK; Leszczynski J; Gupta RK; Siber GR
Biologicals; 1996 Mar; 24(1):41-9. PubMed ID: 8733600
[TBL] [Abstract][Full Text] [Related]
11. Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh.
Hayford KT; Al-Emran HM; Moss WJ; Shomik MS; Bishai D; Levine OS
J Virol Methods; 2013 Nov; 193(2):512-8. PubMed ID: 23872267
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with haemagglutination inhibition, immunofluorescence and plaque neutralization tests.
de Souza VA; Pannuti CS; Sumita LM; Albrecht P
Rev Inst Med Trop Sao Paulo; 1991; 33(1):32-6. PubMed ID: 1843394
[TBL] [Abstract][Full Text] [Related]
13. [Gelatin particle agglutination (PA) antibody: comparison to neutralizing antibody (NT) and hemagglutination inhibition (HI) antibody and relationship to IgG avidity].
Saika S; Matsunaga T; Ogawa T; Ichinohe S
Kansenshogaku Zasshi; 2008 Jul; 82(4):310-6. PubMed ID: 18697482
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the results of two analytical methods for measuring measles virus neutralizing antibodies in source plasma and therapeutic immunoglobulin products.
Hong J; Kim D; Won Y; Yoon J; Park KJ; Oh J; Kim CW
Biologicals; 2019 May; 59():20-28. PubMed ID: 30992162
[TBL] [Abstract][Full Text] [Related]
15. A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody.
Lee MS; Cohen B; Hand J; Nokes DJ
J Virol Methods; 1999 Mar; 78(1-2):209-17. PubMed ID: 10204711
[TBL] [Abstract][Full Text] [Related]
16. High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases.
Sowers SB; Rota JS; Hickman CJ; Mercader S; Redd S; McNall RJ; Williams N; McGrew M; Walls ML; Rota PA; Bellini WJ
Clin Vaccine Immunol; 2016 Aug; 23(8):707-16. PubMed ID: 27335386
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of different measles IgG assays based on recombinant proteins using a panel of low-titre sera.
Hartter HK; de Swart RL; Hanses F; Vos HW; Bouche FB; Osterhaus AD; Schneider F; Muller CP
J Virol Methods; 2000 Feb; 84(2):191-200. PubMed ID: 10680969
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Jamestown Canyon virus in the Japanese general population.
Kato H; Satoh M; Kawahara M; Kitaura S; Yoshikawa T; Fukushi S; Dimitrova K; Wood H; Saijo M; Takayama-Ito M
BMC Infect Dis; 2020 Oct; 20(1):790. PubMed ID: 33096994
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the neutralizing and ELISA antibody titres to human cytomegalovirus (HCMV) in human sera and in gamma globulin preparations.
Schmitz H; Essuman S
J Med Virol; 1986 Oct; 20(2):177-82. PubMed ID: 2430051
[TBL] [Abstract][Full Text] [Related]
20. Qualitative Variation among Commercial Immunoassays for Detection of Measles-Specific IgG.
Latner DR; Sowers SB; Anthony K; Colley H; Badeau C; Coates J; Wong P; Fakile Y; Interiano C; Pannell KB; Leung-Pineda V; Patel MM; Rota PA; Limbago BM; Hickman CJ
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32238434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
